Search Results: Biotechnology
-
Life Sciences
Huron’s life sciences experts help pharmaceutical, medical device and biotechnology firms embrace strategies and technologies to deliver value and improve outcomes.
-
Volkan Duygun
For more than 20 years, Volkan has used both his hands-on and technical expertise to assist clients in developing, implementing and sustaining large strategic IT transformations. His work enables clients to create long-term success while remaining flexible in rapidly changing markets.
-
Pontus Siren
Pontus is a strategy expert who advises leaders across industries on the innovation strategy, capabilities and culture needed to drive growth and stay ahead of market disruption.
-
Ned Calder
Ned is a partner and leader of the industrial and technology solutions team at Innosight, Huron’s strategy and innovation business.
-
Gill Sawhney
Gill is an investment and merchant banking professional with over 25 years of experience building and leading healthcare practices for premier investment banking firms ranging from the largest global firms to industry-focused boutiques. He has executed complex financial transactions and championed his clients’ growth strategies to transform a broad range of life sciences and healthcare organizations.
-
David Weir
David has nearly 30 years of experience helping clients across many industries innovate in areas such as organizational strategy, operational efficiency, strategic change management, and human capital management, as well as in communications and culture.
-
Strategic Solutions For Cancer Centers
Our team of experienced cancer center leaders tailor approaches and solutions to your center's goals, issues and organizational environment.
-
When to Disrupt the Board of Directors
Organizations need to proactively evolve their board of directors in order to confront industry disruption, new business models and shareholder pressure.
-
Resources for Life Sciences Leaders Navigating COVID-19 Business Disruption
View the collection of educational resources to help address the most pressing challenges life sciences organizations are facing as a result of COVID-19.